高コレステロール血症(Hypercholesterolemia):グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Hypercholesterolemia Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hypercholesterolemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hypercholesterolemia 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Hypercholesterolemia Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Hypercholesterolemia 38
Apr 01, 2014: Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese Study 38
Mar 30, 2014: Data From Phase 3 Pivotal Studies Show Amgen’s Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins 38
Mar 30, 2014: Evolocumab safely drops LDL cholesterol well below statin-only baseline 41
Mar 29, 2014: New Detailed Data from Three Phase 3 Pivotal Studies Show Amgen’s Novel Investigational Cholesterol-Lowering Medicine Evolocumab Significantly Reduced LDL Cholesterol By 55-66 Percent Compared To Placebo In Patients With High Cholesterol 42
Dec 19, 2013: Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab In Patients With High Cholesterol 44
Clinical Trial Profiles 46
Clinical Trial Overview of Top Companies 46
Merck & Co., Inc. 46
Clinical Trial Overview of Merck & Co., Inc. 46
AstraZeneca PLC 56
Clinical Trial Overview of AstraZeneca PLC 56
Sanofi 64
Clinical Trial Overview of Sanofi 64
Pfizer Inc. 69
Clinical Trial Overview of Pfizer Inc. 69
Regeneron Pharmaceuticals, Inc. 72
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 72
Aegerion Pharmaceuticals, Inc. 75
Clinical Trial Overview of Aegerion Pharmaceuticals, Inc. 75
Novartis AG 77
Clinical Trial Overview of Novartis AG 77
Kowa Company, Ltd. 79
Clinical Trial Overview of Kowa Company, Ltd. 79
Isis Pharmaceuticals, Inc. 81
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 81
Amgen Inc. 83
Clinical Trial Overview of Amgen Inc. 83
Clinical Trial Overview of Top Institutes / Government 85
National Heart, Lung, and Blood Institute 85
Clinical Trial Overview of National Heart, Lung, and Blood Institute 85
University of Manitoba 87
Clinical Trial Overview of University of Manitoba 87
Gachon University Gil Hospital 88
Clinical Trial Overview of Gachon University Gil Hospital 88
University of Pennsylvania 89
Clinical Trial Overview of University of Pennsylvania 89
University of Toronto 90
Clinical Trial Overview of University of Toronto 90
Osaka University 91
Clinical Trial Overview of Osaka University 91
University of Jena 92
Clinical Trial Overview of University of Jena 92
Maastricht University Medical Center 93
Clinical Trial Overview of Maastricht University Medical Center 93
Washington University School of Medicine 94
Clinical Trial Overview of Washington University School of Medicine 94
Monash University 95
Clinical Trial Overview of Monash University 95
Five Key Clinical Profiles 96
Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 202


【レポート販売概要】

■ タイトル:高コレステロール血症(Hypercholesterolemia):グローバル臨床試験レビュー(2014年上半期)
■ 英文:Hypercholesterolemia Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC2116CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。